Alkermes Inc. plc
ALKSAlkermes Inc. plc (ALKS) is a biopharmaceutical company that specializes in developing innovative medicines for central nervous system (CNS) disorders, addiction, and oncology. The company focuses on utilizing advanced drug delivery technology to improve the effectiveness and convenience of its therapies. Alkermes has a history of developing both proprietary and partnered treatments, with an emphasis on integrating science and technology to address complex medical conditions.
Company News
Avadel Pharmaceuticals announced the mailing of a proxy statement regarding its proposed acquisition by Alkermes, with scheme and extraordinary general meetings scheduled for January 12, 2026, to vote on the transaction.
Orchestra BioMed Holdings, Inc. (OBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Investors should consider this list of healthcare stocks for 2024
The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.
